N/A
N=131
Computer-Delivered Intervention for Individuals With Obesity and Elevated Anxiety Sensitivity
Obesity · Anxiety Sensitivity · Eating · Physical Activity
Bottom Line
View on ClinicalTrials.gov: NCT03917901 ↗Enrolled (actual)
131
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Anxiety Sensitivity Index-3 — 43.44; 43.00; 40.17; 40.69 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Anxiety Sensitivity Training (Other); Health Control (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Houston
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Anxiety Sensitivity Index-3 |
43.44; 43.00; 40.17; 40.69; 38.00; 37.24 | — |
| PRIMARY Dutch Eating Behavior Questionnaire |
3.58; 3.68; 3.54; 3.59; 3.31; 3.52 | — |
| PRIMARY Eating Expectancy Inventory |
88.17; 90.06; 85.98; 89.03; 82.19; 88.30 | — |
| PRIMARY Exercise Self-Efficacy |
14.11; 16.59; 16.37; 18.06; 15.52; 17.54 | — |
Summary
The proposed study will design and evaluate a computerized-delivered single-session anxiety sensitivity reduction program (i.e., Anxiety Sensitivity Training; AST). The AST will be designed to achieve three primary aims: (1) provide psycho-educational information on AS and its consequences, (2) present psycho-educational information on the relationship between AS and obesity-related health behavior correlates, and (3) offer concrete, evidence-based strategies to facilitate motivation to change their obesity-related lifestyle behaviors.
Eligibility Criteria
Inclusion Criteria
- Have a body mass index of at least 30
- Endorse elevated anxiety sensitivity defined as an ASI-3 score of 17 or greater
Exclusion Criteria
- Any anticipated matters that would interfere with participating in the study
- Not being fluent in English
Data sourced from ClinicalTrials.gov (NCT03917901). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.